Literature DB >> 9305246

Submucosal tumor extension in hypopharyngeal cancer.

C M Ho1, W F Ng, K H Lam, W J Wei, A P Yuen.   

Abstract

OBJECTIVES: To study the incidence and extent of submucosal tumor extension in hypopharyngeal cancer and to evaluate the impact on the tumor recurrence and overall survival rates.
METHODS: Fifty-seven resected specimens of hypopharyngeal cancer were studied in detail from January 1986 to December 1989 by use of the whole-organ, step-serial sectioning technique.
RESULTS: Three types of submucosal tumor extension could be identified. Type I extension was characterized by a tumor with a smooth round contour that extended submucosally. The mucosa was thereby elevated and was detectable on gross inspection at operation. In type II extension, tongues and islands of tumor infiltrated within the submucosa, and these were not noticeable on gross examination. Skip metastasis in the submucosa where the submucosal tumor was completely separated from the main tumor bulk was classified as type III extension. Thirty-three patients (58%) had submucosal tumor extension. The frequencies (and extents of submucosal tumor extension) in the superior, medial, lateral, and inferior directions were 16% (3-10 mm), 37% (2-37 mm), 26% (2-37 mm), and 28% (3-35 mm), respectively. Two thirds of the submucosal extension was type I (22 of 33), and only 1 patient had a true skip lesion submucosally (type III extension). Type II submucosal extension was found in one third of the patients (11 of 33). This occurred significantly more often in the patients who had received radiotherapy before surgery (82% [9/11]; P < .001; 95% confidence interval, 1.28-4.44). The presence of submucosal tumor extension had no effect on the tumor recurrence and overall survival rates.
CONCLUSIONS: The incidence of submucosal tumor extensions in hypopharyngeal cancer is high (58%), but most (67%) of them can be detected grossly at operation. The presence of submucosal tumor extension does not adversely affect the survival and tumor recurrence rates.

Entities:  

Mesh:

Year:  1997        PMID: 9305246     DOI: 10.1001/archotol.1997.01900090073010

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  12 in total

1.  Matched-pair analysis of patients with advanced hypopharyngeal cancer: surgery versus concomitant chemoradiotherapy.

Authors:  Shigemichi Iwae; Masato Fujii; Ryuichi Hayashi; Yasuhisa Hasegawa; Takashi Fujii; Kenji Okami; Akihiro Homma; Tetsuro Onitsuka; Takakuni Kato; Takenori Ogawa; Kyoichi Terao; Nobuya Monden; Naoki Otsuki; Hiroshi Nishino; Ichiro Ota; Yasushi Fujimoto; Kazuto Matsuura; Kazuyoshi Kawabata; Hidetoshi Matsui; Koichiro Yonezawa; Ken-Ichi Nibu
Journal:  Int J Clin Oncol       Date:  2017-06-17       Impact factor: 3.402

Review 2.  Site-wise Differences in Adequacy of the Surgical resection Margins in Head and Neck Cancers.

Authors:  Sivakumar Vidhyadharan; Indhu Augustine; Akshay S Kudpaje; Subramania Iyer; Krishnakumar Thankappan
Journal:  Indian J Surg Oncol       Date:  2014-08-07

Review 3.  Squamous-cell carcinoma of the anus: progress in radiotherapy treatment.

Authors:  Rob Glynne-Jones; David Tan; Robert Hughes; Peter Hoskin
Journal:  Nat Rev Clin Oncol       Date:  2016-01-27       Impact factor: 66.675

4.  Free jejunal graft for reconstruction of defects in the hypopharynx and cervical esophagus following the cancer resections.

Authors:  Dean Zhao; Xingqiang Gao; Limei Guan; Wenling Su; Jing Gao; Cunshan Liu; Xianyang Luo; Xiaoyan Li
Journal:  J Gastrointest Surg       Date:  2009-03-31       Impact factor: 3.452

Review 5.  Surgical errors and risks - the head and neck cancer patient.

Authors:  Ulrich Harréus
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2013-12-13

6.  Hypopharyngeal cancer: United Kingdom National Multidisciplinary Guidelines.

Authors:  P Pracy; S Loughran; J Good; S Parmar; R Goranova
Journal:  J Laryngol Otol       Date:  2016-05       Impact factor: 1.469

7.  Definitive Chemoradiotherapy Versus Surgery Followed by Adjuvant Radiotherapy in Resectable Stage III/IV Hypopharyngeal Cancer.

Authors:  Jun Won Kim; Mi Sun Kim; Se-Heon Kim; Joo Hang Kim; Chang Geol Lee; Gwi Eon Kim; Ki Chang Keum
Journal:  Cancer Res Treat       Date:  2015-03-13       Impact factor: 4.679

Review 8.  The clinical target volume in lung, head-and-neck, and esophageal cancer: Lessons from pathological measurement and recurrence analysis.

Authors:  Rudi Apolle; Maximilian Rehm; Thomas Bortfeld; Michael Baumann; Esther G C Troost
Journal:  Clin Transl Radiat Oncol       Date:  2017-03-21

9.  The impact of paratracheal lymph node metastasis in squamous cell carcinoma of the hypopharynx.

Authors:  Young-Hoon Joo; Dong-Il Sun; Kwang-Jae Cho; Jung-Hae Cho; Min-Sik Kim
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-12-01       Impact factor: 2.503

10.  Free posterior tibial flap reconstruction for hypopharyngeal squamous cell carcinoma.

Authors:  Fei Chen; Jun Liu; Lihong Wang; Dan Lv; Yuanzhi Zhu; Qi Wu; Guojun Li; Hongliang Zheng; Xiaofeng Tao
Journal:  World J Surg Oncol       Date:  2014-05-24       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.